![](/img/cover-not-exists.png)
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
Vermeire, Séverine, O'Byrne, Sharon, Keir, Mary, Williams, Marna, Lu, Timothy T, Mansfield, John C, Lamb, Christopher A, Feagan, Brian G, Panes, Julian, Salas, Azucena, Baumgart, Daniel C, Schreiber,Volume:
384
Language:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(14)60661-9
Date:
July, 2014
File:
PDF, 626 KB
english, 2014